ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of …
Writing Committee Members, DL Bhatt, J Scheiman… - Circulation, 2008 - Am Heart Assoc
The use of antiplatelet therapies continues to increase as a result of accumulation of
evidence of benefits in both primary and secondary treatment strategies for cardiovascular …
evidence of benefits in both primary and secondary treatment strategies for cardiovascular …
Combining antiplatelet and anticoagulant therapies
DR Holmes, DJ Kereiakes, NS Kleiman… - Journal of the American …, 2009 - jacc.org
Antiplatelet therapy is the cornerstone for both primary and secondary prevention therapies
for ischemic events resulting from coronary atherosclerotic disease. Dual antiplatelet therapy …
for ischemic events resulting from coronary atherosclerotic disease. Dual antiplatelet therapy …
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI …
Objectives: Our aim was to determine whether a 600-mg loading dose of clopidogrel
compared with 300 mg results in improved clinical outcomes in patients with ST-segment …
compared with 300 mg results in improved clinical outcomes in patients with ST-segment …
Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association
AD Michaels, SA Spinler, B Leeper, EM Ohman… - Circulation, 2010 - Am Heart Assoc
Medical errors are the eighth leading cause of death in the United States and are estimated
to account for somewhere between 44000 and 98000 deaths in the United States each year …
to account for somewhere between 44000 and 98000 deaths in the United States each year …
[PDF][PDF] Managing acute upper GI bleeding, preventing recurrences
M Albeldawi, MA Qadeer, JJ Vargo - Cleve Clin J Med, 2010 - cdn.mdedge.com
Acute upper gastrointestinal (GI) bleeding is common and potentially life-threatening and
needs a prompt assessment and aggressive medical management. All patients need to …
needs a prompt assessment and aggressive medical management. All patients need to …
Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes
JS Berger - The American journal of cardiology, 2013 - Elsevier
Dual antiplatelet therapy is the cornerstone in the management of patients with acute
coronary syndromes (ACS). Ticagrelor, an oral, direct, reversibly binding, P2Y 12 receptor …
coronary syndromes (ACS). Ticagrelor, an oral, direct, reversibly binding, P2Y 12 receptor …
The prevalence and factors associated with aspirin resistance in patients premedicated with aspirin
Objective Aspirin is a key drug used in treating patients with a high risk to develop stroke,
myocardial infarction and other cardiovascular events. However, a considerable fraction of …
myocardial infarction and other cardiovascular events. However, a considerable fraction of …
Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications
V Serebruany, SV Rao, MA Silva… - European heart …, 2010 - academic.oup.com
Aims To correlate inhibition of platelet aggregation (IPA) with bleeding events assessed by
TIMI, GUSTO, and BleedScore™ scales in a large cohort of patients with coronary artery …
TIMI, GUSTO, and BleedScore™ scales in a large cohort of patients with coronary artery …
Protective value of aspirin loading dose on left ventricular remodeling after ST-elevation myocardial infarction
C Calvieri, N Galea, F Cilia, G Pambianchi… - Frontiers in …, 2022 - frontiersin.org
Aims Left ventricular (LV) remodeling after ST-elevation myocardial infarction (STEMI) is a
complex process, defined as changes of LV volumes over time. CMR feature tracking …
complex process, defined as changes of LV volumes over time. CMR feature tracking …
Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature
JS Berger, RH Sallum, B Katona, J Maya… - American Heart …, 2012 - Elsevier
BACKGROUND: Current acetylsalicylic acid (ASA) dosing algorithms for the prevention of
secondary thrombotic events in acute coronary syndrome (ACS) patients are inconsistent …
secondary thrombotic events in acute coronary syndrome (ACS) patients are inconsistent …